NCT02939118View on ClinicalTrials.gov

One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™

CompletedOBSERVATIONAL

Enrollment

51

Participants

Timeline

Start Date

November 7, 2016

Primary Completion Date

February 8, 2024

Study Completion Date

February 8, 2024

Conditions

Type 1 Diabetes Mellitus

Sponsors

Lead Sponsor

All Listed Sponsors

lead

ViaCyte

INDUSTRY